evernorth glp 1 2025 Pharmacy in Focus Report: GLP-1 Drugs Evernorth expanding GLP-1 presence with
Description
In recent days, Hims & Hers Health expanded its platform so clinicians can prescribe Eli Lilly GLP1 weight loss treatments, such as Zepbound vials, KwikPen, and Foundayo, with fulfillment routed through LillyDirect, while also broadening access to Novo Nordisk therapies and strengthening peptide capabilities via a facility acquisition ahead of an FDA review on compounding
Nestl is rolling out Vital, a nutrient-dense protein shake line aimed at aging consumers and the GLP-1 era.
Introduction: Migraine is a prevalent neurological disorder characterized by recurrent headaches with autonomic and neurological symptoms, significantly impacting quality of life globally
For the first time, Medicare will cover GLP-1s for obesity-related weight loss, without any other medical conditions.
What Is the Weight Loss Rate of Semaglutide GLP-1?
